will compound pharmacies stop making semaglutide Compounded semaglutide: What should patients know? States cracking down on compounding
Description
As we discussed before, PDA targets GLP-1 production to induce insulin resistance
A certain change in the RET gene that is passed from parent to child (inherited) may cause medullary thyroid cancer
GLP-1 agonists can also affect the complex system that controls your menstrual cycle and fertility called the hypothalamic-pituitary-ovarian (HPO) axis
doi:10.1056/NEJMoa2500969 Wharton S, Aronne LJ, Stefanski A, et al
This eliminates the cost advantage of overseas manufacturing
How effective are they
